ArticleBiological research2026
UBA5 deficiency disrupts mitochondrial autophagy via the PINK1-parkin pathway and impairs myoblast proliferation.
Article in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancing the frontiers of phytotherapy: a comprehensive review of botanical interventions targeting mitochondrial quality control to ameliorate endometriosis.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Maintaining a healthy and dynamic mitochondrial network is essential for development and for cellular adaptation to physiological and stress conditions. UFMylation is an emerging post-translational modification, yet its involvement in mitochondrial quality control has remained largely unexplored. Here, we establish a previously unrecognized functional link between the UFMylation machinery and mitochondrial homeostasis by identifying the E1-like activating enzyme UBA5 as a key regulator of mitochondrial quality control. We show that UBA5 loss disrupts mitochondrial homeostasis, leading to persistent accumulation of damaged mitochondria and increased ROS accumulation, which in turn triggers p53 activation and DNA damage responses, enforces p21-associated G2/M arrest, and promotes early apoptosis. Mechanistically, although the PINK1–Parkin damage response is engaged, mitophagy execution is inefficient in UBA5-deficient cells, resulting in impaired clearance of dysfunctional mitochondria and exacerbated oxidative stress. Collectively, our findings uncover a previously unreported UFMylation–mitophagy axis and expand current understanding of how UBA5 governs mitochondrial homeostasis and cell fate decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.